Aastha Kohli, M S, RAC (US, EU)
*** ****. ***, #* ******, MA 02115 Phone: 617-***-**** E-Mail:
abobwa@r.postjobfree.com
H ighly self-motivated RA /QA professional with inherent goal-oriented and multi-tasking
skil ls.
G reat eye for detail along with proven organizational, analytical, leadership and
communication skills.
P ROFESSIONAL EXPER I E NCE
Regulatory Affai rs Special ist (contractor), H aemonetics Corporation, MA
J ul 2012-Dec 2012
• Provided support in review and submission of:
- 510(k) (traditional and special) (STED format);
- EU technical files and design dossiers;
- Pre-IDE meeting and IDE request
• Supported Haemonetics acquisition of Pall Corporation:
- US and OUS device registrations and listings;
- Reviewed labels and IFUs for global regulatory compliance;
- Applied for CFGs/COEs/CFSs, and apostille/legalization;
- Submitted Health Canada device (MDL) and establishment licenses (MDEL);
- Worked with global cross-functional teams
• Assisted in preparation for EU Notified Body Inspection
• Worked on CAPAs and recalls
Regulatory Affai rs/Quality Assurance Co-op, Acceleron Pharma, MA
J an 2012-Jun 2012
• Supported quality systems compliance with F DA and EU regulations and ICH
guidelines
• Assisted document control, r isk management, gap analysis, optimization of quality
systems
• Lead the electronic Change Control Management project and created:
- Process mapping
- User Requirement Specifications (URS) and Functional Requirement
Specifications (FRS)
- Installation Qualification (IQ) and Performance Qualification (PQ)
- Risk Assessment, Validation Master Plan (VMP), SOP and conducted t raining
• Assisted the management of change controls, deviation, OOS, NCMRs and CAPA
• Reviewed stability data and batch records
• Assisted supplier quality management
Page 1 of 4
• Supported internal GMP and GLP audits; audit scheduling
• Assisted in reviewing regulatory submission documents for CMC module
Regulatory Affai rs/Quality Assurance I ntern, D r. Reddy’s Laboratories,NJ
J un 2011-Dec 2011
• Supported project management and regulatory strategy group
• Researched and analyzed regulatory requirements to provide updated regulatory
i nformation
• Compiled, reviewed and made regulatory submissions (eCTD format) including
I ND/NDA/ANDA, annual reports and amendments (including information, protocol and
C MC amendments)
• Participated in external GCP and GMP audits and prepared audit reports
• Helped in setting up of quality system
• Assisted in wri ting clinical protocols, reviewing nonclinical and clinical study
reports and maintaining TMF
• Drafted regulatory strategy for using social media in DTCA
• Assisted Pharmacovigilance submissions: PSUR, spontaneous ADEs and 15-Day
a lert reports
• Helped in regulatory operations like OPDP submissions, Structured Product
L abeling (SPL) and drug listing
C linical Pha rm acy Pr actice I ntern, H CG Medisurge Hospitals, India
J an 2010-Jun 2010
• Patient counseling, dispensing, audits, adverse events and medication errors
reporting & documentation
Q uality Assurance Associate in Production Department, Merril Pharma Pvt. L td.,
I ndia Nov 2008–Aug 2009
• Provided Quality Control(QC) support in manufacturing operations of drugs
p roducts
• Assisted in document control-preparation and archiving of SOPs, batch
manufacturing records (BMR), and internal audit reports
A astha Kohli, M S, RAC (US, EU)
395 Mass. Ave, #4 Boston, MA 02115 Phone: 617-***-**** E-Mail:
abobwa@r.postjobfree.com
ED UCAT ION
Page 2 of 4
M .S. Regulatory Affai rs for D rugs, Biologics and Medical Devices, Northeastern
U niversity, USA J un 2012
GPA: 3.7/4.0
B achelor of Pharmacy Honors, N i rma University, Institute of Pharmacy, India
J ul 2010
GPA: 4.0/4.0
B achelor of Pharmacy, Rajiv Gandhi University, India
Oct 2008
T hesis: Estimation of Hypoglycemic Activity in STZ induced Diabetic Rats via SD and MD
s tudies
GPA: 4.0/4.0
CERT I F ICAT IONS
Regulatory Affairs Certification (RAC) – US and EU
P UBL ICAT IONS
Aastha Kohli & Shrenik Desai. How Do You Define Regulatory Compliance? Regulatory Focus,
J uly ‘11; 16(7):36-42
A astha Kohli & Shrenik Desai. Nanomedicine: Current Regulatory Scenario and Prophylactic
Regulatory Strategies. Regulatory Focus, January ’12; 1-7
K NOWLEDGE AND SK I L LS
R egulatory Affai rs:
• I ND, NDA, ANDA, BLA, IDE, PMA & 510(k) submissions with 21 CFR part 807,
312, 314 & ICH guidelines
• Clinical : GCP and GLP regulations
• Quality : GMP regulations including 21 CFR part 210, 211, 820, ISO 13485:2003,
I SO 14971
• Global device regulations including USA, Europe, Canada, Asia-Pacific and Latin
A merica
Computer Systems:
• Proficient in Microsoft Office, SharePoint, Visio, Agile, Oracle, Adobe, Lotus Notes,
M aster Control, QUMAS, Tarius, Cit r ix Docubridge and Labelbridge.
H ONORS AND ACH I EVE M E N TS
• Best Graduate Student Award 2012, Northeastern University, USA
• International Student Dean’s Scholarship (Top 5%), Northeastern University, USA
Page 3 of 4
• Recipient of Gold Medal for Academic Excellence (2005-08); Recipient of Best Student
Award (2004-08); Recipient of University Ranks, (2005-08) (Top 3%), Rajiv Gandhi University of
Health Sciences, India
L EADERSH I P ROLES
Event Organization Support, RAPS NY/NJ and Boston Chapter, Medical
Development Group (MDG) meetings
Or ientation Leader, I n ternational Student and Scholar Institu te (ISSI), Northeastern
U niversity
Event Organization Volunteer, South Asian (Bone) Mar row Association of Recruiters
(SAMAR)
Page 4 of 4